CAPLIPOINT vs VIYASH: Stock Comparison

Caplin Point Laboratories Limited vs Viyash Scientific Ltd

Live data: 22 July 2026, 3:01 PM IST • Source: NSE and company filings

Caplin Point Laboratories Limited is the larger company by market capitalisation. Caplin Point Laboratories Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Caplin Point Laboratories Limited and Viyash Scientific Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, CAPLIPOINT is more favourable on 10 of 13 scored metrics and VIYASH on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
CAPLIPOINT is the larger company
₹18,839 Cr vs ₹11,242 Cr
P/E Ratio
CAPLIPOINT has a lower P/E
31.01x vs 65.27x
P/B Ratio
VIYASH has a lower P/B
3.98x vs 5.54x
EPS
CAPLIPOINT has higher earnings per share
₹83.98 vs ₹4.06
Dividend Yield
CAPLIPOINT has a higher dividend yield
0.3% vs 0%
Revenue Growth (TTM YoY)
CAPLIPOINT has faster revenue growth
19% vs 0%
EPS Growth (TTM YoY)
CAPLIPOINT has faster EPS growth
19.4% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
129% vs 19.4%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricCAPLIPOINTVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricCAPLIPOINTVIYASH
Live Price₹2,483.9₹257.35
Day Change-4.76%-2.94%
Volume1.65 L11.14 L
52-Week High₹2,699₹298
52-Week Low₹1,500.3₹178.13
Distance from 52W High-7.97%-13.64%

Valuation

MetricCAPLIPOINTVIYASH
Market Cap₹18,839 Cr₹11,242 Cr
P/E Ratio31.01x65.27x
P/B Ratio5.54x3.98x
EPS₹83.98₹4.06
Book Value₹462.02₹66.6
Dividend Yield0.3%0%

Growth

MetricCAPLIPOINTVIYASH
Revenue Growth (TTM YoY)19%0%
EPS Growth (TTM YoY)19.4%0%
Qtr Sales Growth19.4%129%
Qtr Profit Growth19.3%455%

Profitability & Leverage

MetricCAPLIPOINTVIYASH
ROE20.6%11%
ROCE24.6%19%
Net Margin29.2%6.57%
Operating Margin34.8%19.1%
Debt to Equity0x0.17x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricCAPLIPOINTVIYASH
Promoter Holding70.57%0%
FII Holding6.15% 0.44 pp2.94% 0.22 pp
DII Holding2.14% 0.09 pp7.99% 0.63 pp
Public Holding21.14% 0.35 pp27.67% 0.3 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Caplin Point Laboratories Limited and Viyash Scientific Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.